First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Update

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the recipient of a significant decline in short interest in the month of May. As of May 29th, there was short interest totaling 24,273 shares, a decline of 38.0% from the May 14th total of 39,179 shares. Currently, 0.2% of the shares of the company are sold short. Based on an average daily volume of 24,573 shares, the days-to-cover ratio is currently 1.0 days.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 0.6%

First Trust NYSE Arca Biotechnology Index Fund stock traded down $1.28 during mid-day trading on Tuesday, reaching $226.42. The company’s stock had a trading volume of 35,158 shares, compared to its average volume of 133,493. The firm has a market cap of $2.56 billion, a price-to-earnings ratio of 21.72 and a beta of 0.68. The business has a 50 day moving average price of $211.71 and a 200-day moving average price of $209.35. First Trust NYSE Arca Biotechnology Index Fund has a twelve month low of $157.51 and a twelve month high of $229.39.

Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Hedge funds have recently added to or reduced their stakes in the business. Dynamic Wealth Strategies LLC lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 10.8% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 515 shares of the company’s stock valued at $106,000 after buying an additional 50 shares during the last quarter. Sequent Planning LLC lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 4.5% in the first quarter. Sequent Planning LLC now owns 1,150 shares of the company’s stock valued at $231,000 after buying an additional 50 shares during the last quarter. Kestra Private Wealth Services LLC lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 0.6% in the fourth quarter. Kestra Private Wealth Services LLC now owns 8,919 shares of the company’s stock valued at $1,842,000 after buying an additional 53 shares during the last quarter. Signaturefd LLC lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 30.6% in the fourth quarter. Signaturefd LLC now owns 235 shares of the company’s stock valued at $49,000 after buying an additional 55 shares during the last quarter. Finally, Bedell Frazier Investment Counselling LLC lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 1.8% in the third quarter. Bedell Frazier Investment Counselling LLC now owns 3,200 shares of the company’s stock valued at $574,000 after buying an additional 57 shares during the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.